The Endocannabinoid System as a Therapeutic Target in Glaucoma

por Cairns, Elizabeth A., Baldridge, William H., Kelly, Melanie E. M.
Publicado 2016

The Cannabinoids Δ(8)THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation

por Thapa, Dinesh, Cairns, Elizabeth A., Szczesniak, Anna-Maria, Toguri, James T., Caldwell, Meggie D., Kelly, Melanie E. M.
Publicado 2018

Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years

por MacPhail, Sara L., Bedoya-Pérez, Miguel A., Cohen, Rhys, Kotsirilos, Vicki, McGregor, Iain S., Cairns, Elizabeth A.
Publicado 2022

Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11

por Kevin, Richard C., Cairns, Elizabeth A., Boyd, Rochelle, Arnold, Jonathon C., Bowen, Michael T., McGregor, Iain S., Banister, Samuel D.
Publicado 2022

Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation

por Thapa, Dinesh, Cairns, Elizabeth A., Szczesniak, Anna-Maria, Kulkarni, Pushkar M., Straiker, Alex J., Thakur, Ganesh A., Kelly, Melanie E. M.
Publicado 2020

Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing

por Cairns, Elizabeth A., Benson, Melissa J., Bedoya-Pérez, Miguel A., Macphail, Sara L., Mohan, Adith, Cohen, Rhys, Sachdev, Perminder S., McGregor, Iain S.
Publicado 2023

Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analo...

por Sparkes, Eric, Boyd, Rochelle, Chen, Shuli, Markham, Jack W., Luo, Jia Lin, Foyzun, Tahira, Zaman, Humayra, Fletcher, Charlotte, Ellison, Ross, McGregor, Iain S., Santiago, Marina J., Lai, Felcia, Gerona, Roy R., Connor, Mark, Hibbs, David E., Cairns, Elizabeth A., Glass, Michelle, Ametovski, Adam, Banister, Samuel D.
Publicado 2022